FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940884097> ?p ?o ?g. }

• W2940884097 endingPage "e0214364" @default.
• W2940884097 startingPage "e0214364" @default.
• W2940884097 abstract "Parkinson disease (PD) is associated with cognitive impairment. We aimed to determine the effects of intranasal insulin (INI) on cognition and motor performance in PD. This was a proof of concept, randomized, double-blinded, placebo-controlled trial evaluating the effects of 40 international units (IU) of insulin or saline once daily for four weeks on cognitive and functional performance. Of 16 subjects enrolled, eight in the INI group and six in the placebo group completed verbal fluency (FAS), Unified Parkinson Disease Scale (UPDRS), and modified Hoehn and Yahr scale (HY, PD severity) at baseline and post-treatment and were included in the analyses. After treatment, the INI group had a better total FAS score (p = 0.02) (41 ± 8.2 vs. 30.8 ± 7.1, mean ±SD, p = 0.02) compared to the placebo group. The INI group also had improved HY (p = 0.04) and UPDRS-Motor (Part III) (p = 0.02) scores when compared to baseline. One INI treated patient with multiple system atrophy (MSA) remained stable and did not show disease progression. The placebo group had no change. INI administration was well tolerated and there were no hypoglycemic episodes or serious study related adverse events or medications interactions. INI is safe in PD and MSA patients and may provide clinically relevant functional improvement. Larger studies are warranted to determine the INI effect in treatment of cognitive and motor impairment in Parkinson disease. Trial Registration: ClinicalTrial.gov NCT02064166." @default.
• W2940884097 created "2019-05-03" @default.
• W2940884097 creator A5034176056 @default.
• W2940884097 creator A5065937266 @default.
• W2940884097 creator A5074227958 @default.
• W2940884097 date "2019-04-25" @default.
• W2940884097 modified "2023-10-17" @default.
• W2940884097 title "Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study" @default.
• W2940884097 cites W1527910050 @default.
• W2940884097 cites W1592438285 @default.
• W2940884097 cites W1862370523 @default.
• W2940884097 cites W1908903040 @default.
• W2940884097 cites W1977761644 @default.
• W2940884097 cites W1978529683 @default.
• W2940884097 cites W1993653633 @default.
• W2940884097 cites W2011937112 @default.
• W2940884097 cites W2015749893 @default.
• W2940884097 cites W2023075542 @default.
• W2940884097 cites W2026850878 @default.
• W2940884097 cites W2031547184 @default.
• W2940884097 cites W2056288823 @default.
• W2940884097 cites W2060932934 @default.
• W2940884097 cites W2064963539 @default.
• W2940884097 cites W2067726982 @default.
• W2940884097 cites W2094790509 @default.
• W2940884097 cites W2112186260 @default.
• W2940884097 cites W2126008330 @default.
• W2940884097 cites W2129597913 @default.
• W2940884097 cites W2133195405 @default.
• W2940884097 cites W2133374742 @default.
• W2940884097 cites W2152774501 @default.
• W2940884097 cites W2153284686 @default.
• W2940884097 cites W2156013560 @default.
• W2940884097 cites W2159296038 @default.
• W2940884097 cites W2160660329 @default.
• W2940884097 cites W2165758561 @default.
• W2940884097 cites W2267206945 @default.
• W2940884097 cites W2336987540 @default.
• W2940884097 cites W2519960383 @default.
• W2940884097 cites W2791725126 @default.
• W2940884097 cites W2792857395 @default.
• W2940884097 cites W328234281 @default.
• W2940884097 doi "https://doi.org/10.1371/journal.pone.0214364" @default.
• W2940884097 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6483338" @default.
• W2940884097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31022213" @default.
• W2940884097 hasPublicationYear "2019" @default.
• W2940884097 type Work @default.
• W2940884097 sameAs 2940884097 @default.
• W2940884097 citedByCount "56" @default.
• W2940884097 countsByYear W29408840972020 @default.
• W2940884097 countsByYear W29408840972021 @default.
• W2940884097 countsByYear W29408840972022 @default.
• W2940884097 countsByYear W29408840972023 @default.
• W2940884097 crossrefType "journal-article" @default.
• W2940884097 hasAuthorship W2940884097A5034176056 @default.
• W2940884097 hasAuthorship W2940884097A5065937266 @default.
• W2940884097 hasAuthorship W2940884097A5074227958 @default.
• W2940884097 hasBestOaLocation W29408840971 @default.
• W2940884097 hasConcept C126322002 @default.
• W2940884097 hasConcept C142724271 @default.
• W2940884097 hasConcept C1862650 @default.
• W2940884097 hasConcept C197934379 @default.
• W2940884097 hasConcept C204787440 @default.
• W2940884097 hasConcept C27081682 @default.
• W2940884097 hasConcept C2779134260 @default.
• W2940884097 hasConcept C2779734285 @default.
• W2940884097 hasConcept C2781172350 @default.
• W2940884097 hasConcept C71924100 @default.
• W2940884097 hasConceptScore W2940884097C126322002 @default.
• W2940884097 hasConceptScore W2940884097C142724271 @default.
• W2940884097 hasConceptScore W2940884097C1862650 @default.
• W2940884097 hasConceptScore W2940884097C197934379 @default.
• W2940884097 hasConceptScore W2940884097C204787440 @default.
• W2940884097 hasConceptScore W2940884097C27081682 @default.
• W2940884097 hasConceptScore W2940884097C2779134260 @default.
• W2940884097 hasConceptScore W2940884097C2779734285 @default.
• W2940884097 hasConceptScore W2940884097C2781172350 @default.
• W2940884097 hasConceptScore W2940884097C71924100 @default.
• W2940884097 hasFunder F4320337357 @default.
• W2940884097 hasIssue "4" @default.
• W2940884097 hasLocation W29408840971 @default.
• W2940884097 hasLocation W29408840972 @default.
• W2940884097 hasLocation W29408840973 @default.
• W2940884097 hasLocation W29408840974 @default.
• W2940884097 hasLocation W29408840975 @default.
• W2940884097 hasOpenAccess W2940884097 @default.
• W2940884097 hasPrimaryLocation W29408840971 @default.
• W2940884097 hasRelatedWork W1859326399 @default.
• W2940884097 hasRelatedWork W1966127473 @default.
• W2940884097 hasRelatedWork W1974781192 @default.
• W2940884097 hasRelatedWork W1992458659 @default.
• W2940884097 hasRelatedWork W2074965717 @default.
• W2940884097 hasRelatedWork W2081991953 @default.
• W2940884097 hasRelatedWork W2085650940 @default.
• W2940884097 hasRelatedWork W2085830368 @default.
• W2940884097 hasRelatedWork W2119160676 @default.
• W2940884097 hasRelatedWork W4311679548 @default.
• W2940884097 hasVolume "14" @default.

• next